Diagnostic and Interventional Cardiology

$The U.S. Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) from AstraZeneca and granted priority review for dapagliflozin (Farxiga) to reduce the risk of cardiovascular (CV) death or the worsening of heart failure (HF) in adults with heart failure with reduced ejection fraction (HFrEF) with and without type 2 diabetes (T2D).$

News

Dapagliflozin Granted FDA Priority Review for Heart Failure With Reduced Ejection Fraction

January 7, 2020 — The U.S. Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) ...

January 07, 2020

Videos | Magnetic Resonance Imaging (MRI)

VIDEO: Use of Cardiac MRI in Congenital and Women's Heart Disease

Karen Ordovas, M.D., MAS, professor of radiology and cardiology at the University of California San Francisco (UCFS) ...

January 06, 2020

The top two articles on DAIC from 2019 included the FDA approval of two transcatheter aortic valve replacement (TAVR) systems for all surgical risk categories, making TAVR available to all patients based on recommendations by the heart team. The second biggest story of 2019 was the release of new atrial fibrillation guidelines recommend novel oral anticoagulants (NOACs) over the previous standard of care warfarin.

Feature

Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from 2019 based on the analytics of its record 3.1 million pageviews.

January 03, 2020

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

News | Cath Lab | Dave Fornell, Editor

EXCEL Trial Authors Say European Surgery Society Claims of Bad Science Are Groundless

January 2, 2020 — In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) ...

January 02, 2020

This photo is from a MitraClip procedure during the University of Colorado visit last December.

Feature | Dave Fornell, Editor

Top 25 Cardiology Videos on DAIC in 2019

Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These the ...

December 30, 2019

News | Radial Access

Merit Medical Announces its EVOlution in Radial Hemostasis in Europe

December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in ...

December 30, 2019

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

News | EP Lab

ElectroSonix Licenses University of Arizona Patents for Acoustoelectric Imaging

December 30, 2019 — Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the ...

December 30, 2019

News | Pharmaceuticals

Study Finds Drug Therapy for High Triglycerides to Have a Sustained Effect Using Low Dosages

December 30, 2019 — A drug therapy targeting the production of a protein produced by the liver has led to sustained and ...

December 30, 2019

Cath Lab Philips Azurion angiography PCI

News | Cardiovascular Business

Study: Patients Overestimate Benefits of PCI

December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures. For ...

December 30, 2019

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

News | Stethoscopes

Eko Announces Redesigned CORE Product Line

December 30, 2019 — Eko, a digital health company with an AI-powered cardiac screening platform, announced the second ...

December 30, 2019

The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).

Feature | Antiplatelet and Anticoagulation Therapies

FDA Clears First Generics for Eliquis

December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of ...

December 27, 2019

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

News | Heart Valve Technology

Tissue Engineering Will Disrupt Cardiovascular Implant Market

While transcatheter heart valve replacement and repair devices are growing in popularity due to their delivery and ...

December 26, 2019

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Peter Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.

Feature | EP Lab | J. Peter Weiss, M.D., MSc

Time to Take Another Look at Robotics in Electrophysiology

Robotic technology, which helps carry out repetitive tasks efficiently and precisely, has been gaining ground in society as a whole and industries around the world, including many areas of medicine. In medicine, this technology is well established for conducting laparoscopic surgeries of the abdomen and pelvis, and it is dominating in prostate surgery. Yet the uptake of robotics has been slow in electrophysiology (EP)

December 23, 2019

The high cost of EP mapping and ablation catheters consumes about 60 percent of CMS reimbursement for atrial fibrillation catheter ablation procedures. This has led some hospitals to start reprocessing the catheters to cut costs.

Blog | Cardiovascular Business

Integrating Cath and EP Lab Reprocessing With OM Technology Development

With all eyes on rising healthcare costs, reprocessing of single-use devices has become an increasingly important ...

December 23, 2019

Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)

News | Cardiovascular Clinical Studies

Top Cardiology News in 2019 From the European Society of Cardiology (ESC)

Environmental and lifestyle issues were popular this year, with pick up from both European Society of Cardiology (ESC) ...

December 23, 2019